The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 25, 2025

Filed:

Mar. 06, 2023
Applicant:

Centre for Novostics, New Territories, HK;

Inventors:

Yuk-Ming Dennis Lo, Hong Kong, CN;

Rossa Wai Kwun Chiu, Hong Kong, CN;

Kwan Chee Chan, Hong Kong, CN;

Peiyong Jiang, Hong Kong, CN;

Qing Zhou, Hong Kong, CN;

Guannan Kang, Hong Kong, CN;

Rong Qiao, Hong Kong, CN;

Lu Ji, Hong Kong, CN;

Assignee:

Centre for Novostics, New Territories, HK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); C12Q 1/6806 (2018.01); C12Q 1/6851 (2018.01); G16B 20/00 (2019.01); G16B 20/30 (2019.01); G16B 30/10 (2019.01); G16B 40/00 (2019.01); G16B 40/20 (2019.01); G16B 50/00 (2019.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); C12Q 1/6851 (2013.01); G16B 20/00 (2019.02); G16B 20/30 (2019.02); G16B 30/10 (2019.02); G16B 40/00 (2019.02); G16B 40/20 (2019.02); G16B 50/00 (2019.02); C12Q 1/6806 (2013.01); C12Q 2600/154 (2013.01);
Abstract

Fragmentation of cell-free DNA molecules is measured and used for various purposes, including determining methylation, e.g., at a particular site of a DNA molecule, at a particular genomic site in a reference genome for a biological sample (e.g., plasma, serum, urine, saliva) of cell-free DNA of a subject, or for a particular region in the reference genome for the biological sample (also just referred to as a sample). Various types of fragmentation measurements can be used, e.g., end motifs and cleavage profiles. Another purpose is determining a fractional concentration of DNA of a particular tissue type (e.g., clinically-relevant DNA). Another purpose is determining a pathology of a subject using a biological sample including cell-free DNA. The cell-free DNA can be of the subject or of a pathogen (e.g., a virus) in the subject's sample. Sites/regions that are hypermethylated, hypomethylated, 5hmC-enriched, and 5hmC-depleted for a particular tissue type can be used.


Find Patent Forward Citations

Loading…